Forbes April 2, 2024
Katherine Hignett

Tens of thousands of people with type 1 diabetes in England will be offered ‘artificial pancreas’ devices that help regulate their blood sugar automatically.

Consisting of an insulin pump, a continuous glucose monitor and an algorithm, this ‘hybrid closed loop’ technology reduces the amount of input needed by the individual.

But those using the devices will still have to type in information about their food intake.

They’re nicknamed ‘artificial pancreases’ as they are designed to mimic the usual behavior of that organ. In most people, the pancreas automatically releases a hormone called insulin to keep their blood sugar at the right level.

People with type 1 diabetes no longer produce their own insulin, usually because their immune system has mistakenly...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Medical Devices, Patient / Consumer, Provider
Opinion: How physicians should talk to parents of unvaccinated children who have contracted measles
New Approach Leads to Faster Mental Health Help for Youth
5 Wellness Trends That Might Be Secretly Harming You—By A Psychologist
Empowering Women In A Hybrid World: 4 Moves To Drive Innovation
AI Tool Diagnoses Multiple Diseases From One Blood Sample

Share This Article